{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:37:36Z","timestamp":1769909856641,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.prrv.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T22:34:29Z","timestamp":1700433269000},"page":"46-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Learning from cystic fibrosis: How can we start to personalise treatment of Children\u2019s Interstitial Lung Disease (chILD)?"],"prefix":"10.1016","volume":"50","author":[{"given":"Andrew","family":"Bush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.prrv.2023.11.001_b0005","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ppul.23183","article-title":"Childhood interstitial lung disease: A systematic review","volume":"50","author":"Hime","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.prrv.2023.11.001_b0010","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/rccm.200703-393OC","article-title":"ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme","volume":"176","author":"Deutsch","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0015","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1513\/AnnalsATS.201501-064OC","article-title":"Children\u2019s interstitial and diffuse lung disease research network (chILDRN). Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme","volume":"12","author":"Fan","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.prrv.2023.11.001_b0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/his.12185","article-title":"Diffuse lung disease in infancy and childhood: expanding the chILD classification","volume":"63","author":"Rice","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prrv.2023.11.001_b0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/thoraxjnl-2017-210519","article-title":"International management platform for children\u2019s interstitial lung disease p(chILD-EU)","volume":"73","author":"Griese","year":"2018","journal-title":"Thorax"},{"issue":"167","key":"10.1016\/j.prrv.2023.11.001_b0030","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0188-2022","article-title":"ERS CRC chILD-EU group. Diagnostic workup of childhood interstitial lung disease","volume":"32","author":"Nathan","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.prrv.2023.11.001_b0035","doi-asserted-by":"crossref","unstructured":"Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, Casey A, et al; chILD Registry Collaborative. The USnational registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatr Pulmonol. 2023 Jul 4. doi: 10.1002\/ppul.26568.","DOI":"10.1002\/ppul.26568"},{"issue":"2","key":"10.1016\/j.prrv.2023.11.001_b0040","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0001-2020","article-title":"Pulmonary alveolar proteinosis in children","volume":"16","author":"Bush","year":"2020","journal-title":"Breathe"},{"key":"10.1016\/j.prrv.2023.11.001_b0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.prrv.2023.11.001_b0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.prrv.2023.11.001_b0055","article-title":"Janus kinase inhibitors in the treatment of type I interferonopathies: a case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2023.11.001_b0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/thoraxjnl-2015-207349","article-title":"European protocols for the diagnosis and initial treatment of interstitial lung disease in children","volume":"70","author":"Bush","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2023.11.001_b0065","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.3390\/ijms21165882","article-title":"From ivacaftor to triple combination: a systematic review of efficacy and safety of CFTR modulators in people with cystic fibrosis","volume":"21","author":"Gramegna","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.prrv.2023.11.001_b0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0075","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.prrv.2023.11.001_b0080","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"Yu","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.prrv.2023.11.001_b0090","doi-asserted-by":"crossref","unstructured":"Durmowicz AG, Lim R, Rogers H, Rosebraugh CJ, Chowdhury BA. The U.S.FoodandDrugAdministration's Experience with Ivacaftor inCysticFibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial. Ann Am Thorac Soc. 2018; 15: 1-2.","DOI":"10.1513\/AnnalsATS.201708-668PS"},{"issue":"10118","key":"10.1016\/j.prrv.2023.11.001_b0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma \u2013 redefining airways diseases. A Lancet commission","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2023.11.001_b0100","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2023.11.001_b0105","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2023.11.001_b0110","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1164\/rccm.202203-0485OC","volume":"206","author":"Prapa","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.prrv.2023.11.001_b0115","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/ppul.25684","article-title":"Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients","volume":"56","author":"Gothe","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"16","key":"10.1016\/j.prrv.2023.11.001_b0120","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0125","doi-asserted-by":"crossref","unstructured":"Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, et al; chILD Registry Collaborative. The USnational registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatr Pulmonol. 2023 Jul 4. doi: 10.1002\/ppul.26568.","DOI":"10.1002\/ppul.26568"},{"key":"10.1016\/j.prrv.2023.11.001_b0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MCP.0000000000000982","article-title":"Pulmonary alveolar proteinosis - current and future therapeutical strategies","volume":"29","author":"Jehn","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2020.105186","article-title":"Interstitial lung disease in infancy","volume":"150","author":"Bush","year":"2020","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.prrv.2023.11.001_b0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/thoraxjnl-2014-205851","article-title":"Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins","volume":"70","author":"Galambos","year":"2015","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.prrv.2023.11.001_b0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201810-1897OC","article-title":"The S52F FOXF1 mutation inhibits STAT3 signaling and causes alveolar capillary dysplasia","volume":"200","author":"Pradhan","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.prrv.2023.11.001_b0155","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.202207-1332OC","article-title":"Novel FOXF1-stabilizing compound TanFe stimulates lung angiogenesis in alveolar capillary dysplasia","volume":"207","author":"Pradhan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1165\/rcmb.2022-0191OC","article-title":"FOXF1 regulates alveolar epithelial morphogenesis through transcriptional activation of mesenchymal WNT5A","volume":"68","author":"Reza","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.prrv.2023.11.001_b0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thorax-2022-219434","article-title":"ABCA3-related interstitial lung disease beyond infancy","volume":"78","author":"Li","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2023.11.001_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-15-43","article-title":"A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant","volume":"15","author":"Campo","year":"2014","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.prrv.2023.11.001_b0175","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1164\/rccm.201402-0342OC","article-title":"Genotype-phenotype correlations for infants and children with ABCA3 deficiency","volume":"189","author":"Wambach","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2023.11.001_b0180","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.febslet.2010.09.026","article-title":"The surfactant lipid transporter ABCA3 is N-terminally cleaved inside LAMP3-positive vesicles","volume":"584","author":"Engelbrecht","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.prrv.2023.11.001_b0185","unstructured":"Matsumura Y, Ban N, UedaK, Inagaki N. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol."},{"issue":"33","key":"10.1016\/j.prrv.2023.11.001_b0190","doi-asserted-by":"crossref","first-page":"23811","DOI":"10.1074\/jbc.M703927200","article-title":"ABCA3 is critical for lamellar body biogenesis in vivo","volume":"282","author":"Cheong","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0195","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-12-4","article-title":"Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells","volume":"12","author":"Weichert","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.prrv.2023.11.001_b0200","first-page":"1298","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"41","author":"Korfei","year":"2020","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/j.prrv.2023.11.001_b0205","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/humu.24014","article-title":"Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variants","volume":"41","author":"Hu","year":"2020","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.prrv.2023.11.001_b0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/humu.23416","article-title":"ABCA3 missense mutations causing surfactant dysfunction disorders have distinct cellular phenotypes","volume":"39","author":"Schindlbeck","year":"2018","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.prrv.2023.11.001_b0215","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1165\/rcmb.2021-0430LE","article-title":"Instability of mature ABCA3 protein: toward a new classification of ABCA3 mutations?","volume":"67","author":"Onn\u00e9e","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prrv.2023.11.001_b0220","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1111\/jcmm.14397","article-title":"Potentiation of ABCA3 lipid transport function by ivacaftor and genistein","volume":"23","author":"Kinting","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-6-59","article-title":"ATP-binding cassette (ABC) transporters in normal and pathological lung","volume":"6","author":"van der Deen","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.prrv.2023.11.001_b0230","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddy011","article-title":"Functional rescue of misfolding ABCA3 mutations by small molecular correctors","volume":"27","author":"Kinting","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.prrv.2023.11.001_b0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1165\/rcmb.2021-0223OC","article-title":"High-content screening identifies cyclosporin A as a Novel ABCA3-specific molecular corrector","volume":"66","author":"Forstner","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prrv.2023.11.001_b0240","doi-asserted-by":"crossref","unstructured":"Ramalho AS, F\u00fcrstov\u00e1 E, Vonk AM, Ferrante M, Verfaillie C, Dupont L, Boon M, Proesmans M, Beekman JM, Sarouk I, Vazquez Cordero C, Vermeulen F, De Boeck K; Belgian Organoid Project. Correction of CFTR function in intestinalorganoidsto guide treatment of cystic fibrosis. Eur Respir J. 2021; 57: 1902426.","DOI":"10.1183\/13993003.02426-2019"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02399-2","article-title":"Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease","volume":"17","author":"Griese","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.prrv.2023.11.001_b0250","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bbamcr.2017.08.013","article-title":"Quantification of volume and lipid filling of intracellular vesicles carrying the ABCA3 transporter","volume":"1864","author":"H\u00f6ppner","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.prrv.2023.11.001_b0255","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.3390\/ijms24087554","article-title":"Quantifying functional impairment of ABCA3 variants associated with interstitial lung disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.prrv.2023.11.001_b0260","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jmg.2009.066829","article-title":"New surfactant protein C gene mutations associated with diffuse lung disease","volume":"46","author":"Guillot","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.prrv.2023.11.001_b0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ppul.20970","article-title":"Familial interstitial disease with I73T mutation: A mid- and long-term study","volume":"44","author":"Abou Taam","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"18","key":"10.1016\/j.prrv.2023.11.001_b0270","doi-asserted-by":"crossref","first-page":"14658","DOI":"10.1074\/jbc.M011770200","article-title":"Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide","volume":"276","author":"Conkright","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0275","doi-asserted-by":"crossref","first-page":"2100267","DOI":"10.1183\/13993003.00267-2021","article-title":"Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant","volume":"59","author":"Dickens","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2023.11.001_b0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1165\/rcmb.2012-0003OC","article-title":"4-Phenylbutyric acid treatment rescues trafficking and processing of a mutant surfactant protein-C","volume":"47","author":"Stewart","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.prrv.2023.11.001_b0285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1165\/rcmb.2022-0203MA","article-title":"Chronic expression of a clinical SFTPC mutation causes murine lung fibrosis with idiopathic pulmonary fibrosis features","volume":"68","author":"Rodriguez","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.prrv.2023.11.001_b0290","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1165\/rcmb.2003-0262OC","article-title":"Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs","volume":"30","author":"Brasch","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.prrv.2023.11.001_b0295","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.celrep.2016.02.035","article-title":"p73 Is required for multiciliogenesis and regulates the foxj1-associated gene network","volume":"14","author":"Marshall","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0300","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14279","article-title":"X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3","volume":"8","author":"Olcese","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.prrv.2023.11.001_b0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-7-40","article-title":"A national internet-linked based database for pediatric interstitial lung diseases: the French network","volume":"7","author":"Nathan","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.prrv.2023.11.001_b0310","article-title":"A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:57:50Z","timestamp":1716847070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054223000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":62,"alternative-id":["S1526054223000787"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2023.11.001","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learning from cystic fibrosis: How can we start to personalise treatment of Children\u2019s Interstitial Lung Disease (chILD)?","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}